UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B

The Journal of infectious diseases, 2020-07, Vol.222 (4), p.611-618

2020

Volltextzugriff (PDF)

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B

Hepatology research, 2018-02, Vol.48 (3), p.E213-E221

2018

Volltextzugriff (PDF)

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

Hepatology (Baltimore, Md.), 2008-02, Vol.47 (2), p.447-454

2008

Volltextzugriff (PDF)

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

BMC gastroenterology, 2019-05, Vol.19 (1), p.65-65, Article 65

2019

Volltextzugriff (PDF)

Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults

PloS one, 2008-04, Vol.3 (4), p.e1952-e1952

2008

Volltextzugriff (PDF)

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

Clinical gastroenterology and hepatology, 2020-03, Vol.18 (3), p.719-727.e7

2020

Volltextzugriff (PDF)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Gut, 2016-02, Vol.65 (2), p.313-320

2016

Volltextzugriff (PDF)

Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study

Journal of hepatology, 2016-10, Vol.65 (4), p.674-682

2016

Volltextzugriff (PDF)

The 104‐week efficacy and safety of telbivudine‐based optimization strategy in chronic hepatitis B patients: A randomized, controlled study

Hepatology (Baltimore, Md.), 2014-04, Vol.59 (4), p.1283-1292

2014

Volltextzugriff (PDF)

Interpretations of diagnosis and management of chronic hepatitis B in children, young people and adults by NICE (2013)

Zhonghua gan zang bing za zhi, 2014-08, Vol.22 (8), p.561

2014

Volltextzugriff (PDF)

A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2020-02, Vol.51 (4), p.469-478

2020

Volltextzugriff (PDF)

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

Journal of gastroenterology and hepatology, 2015-04, Vol.30 (4), p.748-755

2015

Volltextzugriff (PDF)

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Liver international, 2011-05, Vol.31 (5), p.676-684

2011

Volltextzugriff (PDF)

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

Advances in therapy, 2015-08, Vol.32 (8), p.727-741

2015

Volltextzugriff (PDF)

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Virology journal, 2016-10, Vol.13 (1), p.180-180, Article 180

2016

Volltextzugriff (PDF)

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial

Journal of clinical virology, 2014-12, Vol.61 (4), p.509-516

2014

Volltextzugriff (PDF)

HBsAg and HBeAg in the prediction of a clinical response to peginterferon [alpha]-2b therapy in Chinese HBeAg-positive patients

Virology journal, 2016-10, Vol.13 (1)

2016

Volltextzugriff (PDF)

Efficacy and safety of prolonged 3ayear telbivudine treatment in patients with chronic hepatitis B

Liver international, 2011-05, Vol.31 (5), p.676-684

2011

Volltextzugriff (PDF)

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B: Long-term telbivudine in CHB patients

Liver international, 2011-05, Vol.31 (5), p.676-684

2011

Volltextzugriff (PDF)

Physicochemical and Thermal Characterization of Hydroxyethyl Cellulose - Wheat Starch Based Films Incorporated Thymol Intended for Active Packaging

Sains Malaysiana, 2020-02, Vol.49 (2), p.323-333

2020

Volltextzugriff (PDF)

Microbial study of pH sensitive starch based film using agar diffusion method (zone inhibition assay)

IOP conference series. Materials Science and Engineering, 2019-08, Vol.607 (1), p.12007

2019

Volltextzugriff (PDF)

Analysis of a case of balanced chromosome translocation and phenotypic abnormality by fluorescence in situ hybridization

Zhonghua yi xue yi chuan xue za zhi, 2001-04, Vol.18 (2), p.96

2001

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(14)
Life Sciences & Biomedicine
(14)
Adult
(12)
Female
(12)
Male
(11)
Gastroenterology & Hepatology
(10)
Hepatitis B
(10)
Hepatitis B E Antigens - Blood
(9)
Hepatitis B, Chronic - Drug Therapy
(9)
Treatment Outcome
(8)
Adolescent
(7)
Hepatitis B E Antigen
(7)
Middle Aged
(7)
Young Adult
(6)
Antigens
(5)
Antiviral Agents - Administration & Dosage
(5)
Antiviral Agents - Therapeutic Use
(5)
Hepatitis
(5)
Seroconversion
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study

The 104‐week efficacy and safety of telbivudine‐based optimization strategy in chronic hepatitis B patients: A randomized, controlled study

Interpretations of diagnosis and management of chronic hepatitis B in children, young people and adults by NICE (2013)

A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial

HBsAg and HBeAg in the prediction of a clinical response to peginterferon [alpha]-2b therapy in Chinese HBeAg-positive patients

Efficacy and safety of prolonged 3ayear telbivudine treatment in patients with chronic hepatitis B

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B: Long-term telbivudine in CHB patients

Physicochemical and Thermal Characterization of Hydroxyethyl Cellulose - Wheat Starch Based Films Incorporated Thymol Intended for Active Packaging

Microbial study of pH sensitive starch based film using agar diffusion method (zone inhibition assay)

Analysis of a case of balanced chromosome translocation and phenotypic abnormality by fluorescence in situ hybridization

Suchergebnisse filtern